Oncogene - Table of Contents alert Volume 32 Issue 35

Advertisement Harnessing Oncolytic Virus-mediated Antitumor Immunity Topic editors: Philippe Fournier and Volker Schirrmacher¦ Submission deadline: 31/12/13 This Frontiers in Oncology Research Topic highlights how Oncolytic viruses (OVs) have emerged as a promising anticancer treatment and addresses various strategies of how to optimize OVs anti-tumor activity. Find out more on how you can contribute to this RT. TABLE OF CONTENTS Volume 32, Issue 35 (August 2013) In this issue Review Original Articles Short Communication Letter to the Editor Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Review Top Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis G L Semenza Oncogene 2013 32: 4057-4063; advance online publication, December 10, 2012; 10.1038/onc.2012.578 Abstract | Full Text Original Articles Top Neurotrophin-3 modulates breast cancer cells and the microenvironment to promote the growth of breast cancer brain metastasis E Louie, X F Chen, A Coomes, K Ji, S Tsirka and E I Chen Oncogene 2013 32: 4064-4077; advance online publication, September 24, 2012; 10.1038/onc.2012.417 Abstract | Full Text Brain and testicular tumors in mice with progenitor cells lacking BAX and BAK S G Katz, J K Fisher, M Correll, R T Bronson, K L Ligon and L D Walensky Oncogene 2013 32: 4078-4085; advance online publication, September 17, 2012; 10.1038/onc.2012.421 Abstract | Full Text Krüppel-like factor 4 (KLF4) suppresses neuroblastoma cell growth and determines non-tumorigenic lineage differentiation C K Y Shum, S T Lau, L L S Tsoi, L K Chan, J W P Yam, M Ohira, A Nakagawara, P K H Tam and E S W Ngan Oncogene 2013 32: 4086-4099; advance online publication, October 8, 2012; 10.1038/onc.2012.437 Abstract | Full Text LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap H B Nguyen, J T Babcock, C D Wells and L A Quilliam Oncogene 2013 32: 4100-4109; advance online publication, October 1, 2012; 10.1038/onc.2012.431 Abstract | Full Text Wnt4 inhibits cell motility induced by oncogenic Ras M De Menna, V D'Amato, A Ferraro, A Fusco, R Di Lauro, C Garbi and G De Vita Oncogene 2013 32: 4110-4119; advance online publication, October 1, 2012; 10.1038/onc.2012.419 Abstract | Full Text Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer D Maglic, S Zhu, E A Fry, P Taneja, F Kai, R D Kendig, T Sugiyama, L D Miller, M C Willingham and K Inoue Oncogene 2013 32: 4120-4129; advance online publication, October 8, 2012; 10.1038/onc.2012.423 Abstract | Full Text Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells Open X-B Shi, L Xue, A-H Ma, C G Tepper, R Gandour-Edwards, H-J Kung and R W deVere White Oncogene 2013 32: 4130-4138; advance online publication, October 15, 2012; 10.1038/onc.2012.425 Abstract | Full Text MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer R S Hudson, M Yi, D Esposito, S A Glynn, A M Starks, Y Yang, A J Schetter, S K Watkins, A A Hurwitz, T H Dorsey, R M Stephens, C M Croce and S Ambs Oncogene 2013 32: 4139-4147; advance online publication, September 17, 2012; 10.1038/onc.2012.424 Abstract | Full Text Effect of a natural mutation in the 5′ untranslated region on the translational control of p53 mRNA D Khan, A Sharathchandra, A Ponnuswamy, R Grover and S Das Oncogene 2013 32: 4148-4159; advance online publication, October 1, 2012; 10.1038/onc.2012.422 Abstract | Full Text SUMOylation of ZFP282 potentiates its positive effect on estrogen signaling in breast tumorigenesis Open E J Yu, S-H Kim, M J Kim, W-Y Seo, K-A Song, M-S Kang, C K Yang, M R Stallcup and J H Kim Oncogene 2013 32: 4160-4168; advance online publication, September 17, 2012; 10.1038/onc.2012.420 Abstract | Full Text HER2 stabilizes EGFR and itself by altering autophosphorylation patterns in a manner that overcomes regulatory mechanisms and promotes proliferative and transformation signaling Z Hartman, H Zhao and Y M Agazie Oncogene 2013 32: 4169-4180; advance online publication, October 1, 2012; 10.1038/onc.2012.418 Abstract | Full Text Short Communication Top Distinct roles for fibroblast growth factor signaling in cerebellar development and medulloblastoma B A Emmenegger, E I Hwang, C Moore, S L Markant, S N Brun, J W Dutton, T-A Read, M P Fogarty, A R Singh, D L Durden, C Yang, W L McKeehan and R J Wechsler-Reya Oncogene 2013 32: 4181-4188; advance online publication, October 8, 2012; 10.1038/onc.2012.440 Abstract | Full Text Letter to the Editor Top YB-1 (YBX1) does not bind to Y/CCAAT boxes in vivo D Dolfini and R Mantovani Oncogene 2013 32: 4189-4190; advance online publication, November 19, 2012; 10.1038/onc.2012.521 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.